EU chooses SIGA’s tecovirima to fight Monkeypox SIGA Technologies Inc. (NASDAQ: SIGA) jumped 41.91% after the biotech announced on May 19, 2022, the approval its IV formulation of the TPOXX therapy for smallpox treatment. Another potential...
Read More
Snap Inc. (NYSE: SNAP) was down 43.08% after its CEO Evan Spiegel said that they would considerably slow down recruitment for the remainder of the year and warned that revenue would not grow as fast as anticipated. Spiegel indicated in a memo that...
Read More
SIGA receives FDA approval for IV TPOXX in the US Siga Technologies Inc. (NASDAQ: SIGA) was up 43.35% after announcing the FDA had approved its intravenous (IV) TPOXX formula for smallpox treatment. The formulation is a vital alternative for those...
Read More
Albireo announces its Q1 2022 financial results Albireo Pharma Inc. (NASDAQ: ALBO) was down 18.37% after the company announced its Q1 2022 financial results. CEO and President Ron Cooper said that their launch of Bylvay globally is going as...
Read More
Veru reports revenue of $13.03 million Veru Inc. (NASDAQ: VERU) was up 43.96% after the company announced its Q2 results. The company had revenue of $13.03 million, missing estimates by 14.18%. A year ago, the company had a revenue of $13.34...
Read More
Pfizer to acquire Biohaven for $11.6 Billion Biohaven Pharmaceuticals Holding Company Ltd. (NASDAQ: BHVN) jumped 68.39% after Pfizer Inc. (NYSE: PFE) said it would acquire Biohaven for $11.6 billion. Pfizer is betting on Biohaven Pharmaceuticals’...
Read More
The Arena Group Holdings reports revenue of $48.2 million in Q1 2022 The Arena Group Holdings Inc. (NYSEAMERICAN: AREN) was up 43.54% after the company reported a 44% revenue increase in Q1 2022 to $48.2 million. Gross profit percentage was up 41%...
Read More